Search |

Add/Edit My Facility

TAMU - Combinatorial Drug Discovery Program (CDDP)

Texas A&M Health Science Center

2121 W. Holcombe Blvd

Texas A&M Institute of Biosciences and Technology

Houston, TX 77030

United States

https://vpr.tamu.edu/core_facility/high-throughput-research-and-screening-center/

Facility LIMS Page

iLab

Primary Contact:

Clifford Stephan

Last Updated: 04/27/2022

Facility RRID

RRID:SCR_022214

cite this

Facility Details

The Combinatorial Drug Discovery Program (CDDP) resides in the Texas A&M Health Science Center’s Institute of Biosciences and Technology, Houston, TX. This core provides industry standard high throughput screening and automated microscopy capabilities to scientists performing drug discovery research. The core provides many benefits, such as access to an automated infrastructure that is capable of supporting both both phenotypic and biochemical targets. The CDDP provides ready access to collections of current FDA-approved drugs and clinical candidates exhibiting the ‘drug-like’ qualities of acceptable solubility, desirable ADME/toxicology properties and adequate bioavailability. These properties are important for rapid advancement of new agents into successful preclinical and clinical trials by discovering new therapeutic vulnerabilities alone or in combinations. The CDDP also has collections of mechanistically annotated informer sets that are pathway specific modulators for studying mechanism of action or target identification. The core also has collections of natural products and diverse sets of small molecules that can be interrogated for new target discovery. The greatest benefit of the core; however, is its fulltime professional staff. The screening team is composed of highly experienced biologists, biochemists, pharmacologists and data scientists with both pharmaceutical industry and academic experience. Each project is individually evaluated and a team of scientists from the CDDP is created to fit the specific needs of the project from assay design and development through primary, secondary and orthogonal screening. The team is committed to providing an integrated and highly collaborative program with every investigator.

Facility Policies

Services are offerred outside of Texas A&M Health Science Center

Consulting is offerred outside of Texas A&M Health Science Center